eight – Page 112 – Communicable Diseases Research

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Article

Published on 2020-08-142022-10-04
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, MERS, 변종,

Coronavirus disease 2019 epidemic in impoverished area: Liangshan Yi autonomous prefecture as an example

Case Study

Published on 2020-08-122022-10-29
Journal: Infectious Diseases of Poverty [Category] COVID-19, MERS,

Risk factors of severe cases with COVID-19: a meta-analysis

Original Paper

Published on 2020-08-122022-11-01
Journal: Epidemiology and Infection [Category] COVID-19, MERS,

Early Epidemiological Features of COVID-19 in Nepal and Public Health Response

Medicine

Published on 2020-08-112022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)

Article

Published on 2020-08-112022-10-28
Journal: Biomolecules [Category] COVID-19, MERS,

[키워드] acute renal failure acute respiratory distress Administered administration Adrecizumab adrenomedullin antibody approach ARDS C-reactive protein calculated capillary leakage case sery coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Critical Critically ill died discharged Efficacy eight endothelial function Endothelium expected FIVE Follow-up HAM 8101 High-dose highest humanized ICU Ill inflammatory parameter intensive care interleukin-6 life-threatening low-dose mechanical ventilation median monoclonal Mortality outcome paO2/fiO2 Patient patients procalcitonin ranged renal replacement therapy resource risk Sepsis Seven severity Shock single dose small sample size SOFA SOFA score suffered surviving patient syndrome targeting the disease the patient therapeutic Vascular with COVID-19
[DOI] 10.3390/biom10081171 PMC 바로가기 [Article Type] Article

Massive migration promotes the early spread of COVID-19 in China: a study based on a scale-free network

Research Article

Published on 2020-08-102022-10-29
Journal: Infectious Diseases of Poverty [Category] COVID-19, MERS,

Cloth face masks to prevent Covid-19 and other respiratory infections *

Review Article

Published on 2020-08-102022-10-29
Journal: Revista Latino-Americana de Enfermagem [Category] COVID-19, MERS, SARS,

Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19

Article

Published on 2020-08-102022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] 95% CI ACE2 acute lung injury acute respiratory syndrome adjusted Admission angiotensin-converting enzyme 2 association benefit binding cause collected coronavirus Coronavirus disease 2019 COVID-19 COVID-19 disease COVID-19 mortality drug eight eligible Evidence expression hospitalised hospitalised patient host cell Infection Inflammation Inflammatory initiated medication Mortality multicentre multivariable analysis Non-steroidal anti-inflammatory drugs NSAID NSAIDS outcome Patient patients with COVID-19 protective effect required Research resulting routine SARS-CoV-2 suggested survival UK hospitals viral replication with COVID-19
[DOI] 10.3390/jcm9082586 PMC 바로가기 [Article Type] Article

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial

당뇨병과 같은 동반 질환이 없는 새로 진단된 COVID-19 감염 환자를 치료하기 위한 Hydroxychloroquine, Oseltamivir 및 Azithromycin의 코로나바이러스 치료(PROTECT) 평가를 위한 파키스탄 무작위 및 관찰 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-08-082022-08-13
Journal: Trials [Category] MERS, 임상,

[키워드] 1:1 adaptive age allocation sequence approval authority Azithromycin baseline bioethics blinded Blinding board clinical Clinical improvement clinical status Cohort cohort study Combination combinations Committee Comorbidity comparator computer-generated Controlled trial coronavirus COVID-19 diabete diabetes Diabetes Mellitus diagnosed disease dissemination distress drug dyspneic Effectiveness eight element evaluate excluded expected Final flexibility Follow-up followed by Formal Gender groups Hospitalized Hydroxychloroquine hypertension Infection intervention group kidney Kidney failure lactating liver medical condition monotherapy multi-center multicenter nasal swab nucleic acid number objective observation open open label Ordinal Scale oseltamivir parameter participant patients patients with COVID-19 PCR positive pregnant Primary outcome Primary outcomes protocol public health qRT-PCR random randomization Randomized Randomized controlled trial randomized study recruited recruitment regimen Registered Registration reported respiratory distress Safety Sample size Self-isolation Seven seven-category ordinal scale Standard status Study protocol subject subsequent sulfate test negative tested three groups treat Treatment Trial twice a day Version virus website
[DOI] 10.1186/s13063-020-04616-4 PMC 바로가기 [Article Type] Letter

A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19

4900

Published on 2020-08-072022-10-30
Journal: Medicine [Category] COVID-19, MERS,